NON-INVASIVE CANCER SOLUTIONS     
Safe | Accurate | Easy on the Patient

EXECUTIVE SUMMARY

What Analysis of Cell Free DNA (cfDNA) and Circulating Tumor Associated Cells (C-TACs) to check treatment response / recurrence.
For Whom Patients who have been treated and are required to be monitored for response to treatment or for recurrence.
Why Radiological imaging is not always able to detect changes in the tumor at the molecular level or early signs of recurrence. Additionally, there are inherent risks associated with radiological imaging.
How cfDNA from the patient’s peripheral blood is analysed for qualitative and quantitative changes in targeted genes.
Sample Type 22 ml peripheral blood (5-6 hours fasting) as per protocol.
Turn Around Time 5 days

CONTACT US

Please contact us for more details.

I have read and understood the terms of use and the privacy policy and I agree.